Cited by 533D Printing in Biomedical ResearchCancer Cells and MetastasisNanoparticle-Based Drug Delivery

Recapitulation of complex transport and action of drugs at the tumor microenvironment using tumor-microenvironment-on-chip

Open access
Han, Bumsoo, Qu, Chunjing, Park, Kinam, Konieczny, Stephen F., Korc, Murray·2016·Cancer Letters

Abstract

Targeted delivery aims to selectively distribute drugs to targeted tumor tissues but not to healthy tissues. This can address many clinical challenges by maximizing the efficacy but minimizing the toxicity of anti-cancer drugs. However, a complex tumor microenvironment poses various barriers hindering the transport of drugs and drug delivery systems. New tumor models that allow for the systematic study of these complex environments are highly desired to provide reliable test beds to develop drug delivery systems for targeted delivery. Recently, research efforts have yielded new in vitro tumor models, the so called tumor-microenvironment-on-chip, that recapitulate certain characteristics of the tumor microenvironment. These new models show benefits over other conventional tumor models, and have the potential to accelerate drug discovery and enable precision medicine. However, further research is warranted to overcome their limitations and to properly interpret the data obtained from these models. In this article, key features of the in vivo tumor microenvironment that are relevant to drug transport processes for targeted delivery were discussed, and the current status and challenges for developing in vitro transport model systems were reviewed.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.canlet.2015.12.003

Cites

152 of 152 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

6 of the 158 references couldn’t be matched to a known paper.

Research works printed but not linked: 4

  1. [48]Monsky W Yuan F Fukumura D Torchilin V Jain RK Topical superfusion of vascular endothelial growth factor increases tumor vessel endothelial pore size Proceedings of the American Association for Cancer Research Annual Meeting 1997 38 52
  2. [59]Rubin K Sjoquist M Gustafsson A-M Isaksson B Salvessen G Reed RK Lowering of tumoral interstitial fluid pressure by prostaglandin E1 is paralleled by an increased uptake of Cr-EDTA Int. J. Cancer 2000 86 636 643 10797284
  3. [64]Stein U Walther W Lemm M Naundorf H Fichtner I Development and characterization of novel human multidrug resistant mammary carcinoma lines in vitro and in vivo Int. J. Cancer 1997 72 885 891 9311609
  4. [146]Noe-Kim V Ozcelikkale A Han B An in vitro microfluidic tumor model to mimic ductal carninoma in situ, Proceedings of the 2015 Summer Biomechanics Bioengineering and BIotransport Conference 2015 SB3C2015 673

Cited by

Sorted by citations

Authors
Han, B., Qu, C., Park, K., Konieczny, S. F., & Korc, M.
Affiliations
  • Purdue University West Lafayette (US)
  • Indiana University Indianapolis (US)
Corresponding author
Han, Bumsoo
Venue
Cancer Letters
Publisher
Elsevier BV
Published
2016-09
Volume
380
Issue
1
Pages
319-329
ISSN
0304-3835 (ISSN-L)
OpenAlex
W2193304129
Cited by
53
References
158
Citations by year
2026: 3 · 2025: 3 · 2024: 9 · 2023: 7 · 2022: 1 · 2021: 3 · 2020: 8 · 2019: 7 · 2018: 2 · 2017: 6 · 2016: 4
FWCI
0.31
Type
journal article
Language
en
Open access
Locations
  • Cancer Letters (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • IUScholarWorks (Indiana University) (submittedVersion)
  • Purdue University Indianapolis (Indiana University) (submittedVersion)
Funders
  • NIH (HHSN261201400021C, CA129287, CA124586, CA075059, UL1 TR000006)
  • Walther Cancer Foundation
  • Purdue University
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Keywords
tumor microenvironment, drug transport, targeted drug delivery, in vitro tumor model, drug delivery systems, anticancer agents, precision medicine, drug discovery
MeSH terms
Animals, Antineoplastic Agents, Biological Transport, Drug Carriers, Humans, Micromanipulation, Pancreatic Neoplasms, Drug Delivery Systems, Drug Resistance, Neoplasm, Carcinoma, Pancreatic Ductal, Microchip Analytical Procedures, Microfluidic Analytical Techniques, Cell Proliferation, Drug Discovery, Lab-On-A-Chip Devices, Molecular Targeted Therapy, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review